mci 154 has been researched along with pindolol in 1 studies
| Studies (mci 154) | Trials (mci 154) | Recent Studies (post-2010) (mci 154) | Studies (pindolol) | Trials (pindolol) | Recent Studies (post-2010) (pindolol) |
|---|---|---|---|---|---|
| 65 | 1 | 0 | 3,718 | 662 | 92 |
| Protein | Taxonomy | mci 154 (IC50) | pindolol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0005 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.0009 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 0.088 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.048 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.048 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endoh, M; Kitada, Y; Narimatsu, A; Suzuki, R; Taira, N | 1 |
1 other study(ies) available for mci 154 and pindolol
| Article | Year |
|---|---|
Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
Topics: Animals; Carbachol; Cardiotonic Agents; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Phosphoric Diester Hydrolases; Pindolol; Pyridazines; Reserpine; Stimulation, Chemical; Tetrodotoxin | 1987 |